Vincristine sulfate liposome injection
Showing 1 - 25 of >10,000
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +5 more
- Rituximab
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Jul 19, 2021
Intraocular Retinoblastoma Trial in United States (drug, procedure, biological)
Completed
- Intraocular Retinoblastoma
- liposomal vincristine sulfate
- +5 more
-
Arcadia, California
- +10 more
Jul 12, 2021
Hematologic Diseases Trial (Vincristine Sulfate Liposome, CHOP, R-CHOP)
Unknown status
- Hematologic Diseases
- Vincristine Sulfate Liposome
- +2 more
- (no location specified)
Apr 15, 2020
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5
Withdrawn
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +7 more
- Inotuzumab Ozogamicin
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 13, 2022
Malignant Melanoma Trial in Houston (Vincristine Sulfate Liposomes Injection)
Completed
- Malignant Melanoma
- Vincristine Sulfate Liposomes Injection
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
Dec 10, 2019
Recurrent Adult Acute Myeloid Leukemia Trial in Winston-Salem (Vincristine Sulfate Liposome, Laboratory Biomarker Analysis)
Terminated
- Recurrent Adult Acute Myeloid Leukemia
- Vincristine Sulfate Liposome
- Laboratory Biomarker Analysis
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 31, 2019
Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in San Francisco, Leeds (Vincristine Sulfate
Completed
- Non-Hodgkin's Lymphoma
- +2 more
- Vincristine Sulfate Liposome Injection plus rituximab
-
San Francisco, California
- +1 more
Dec 31, 2019
Intraocular Retinoblastoma Trial in Worldwide (liposomal vincristine sulfate, carboplatin, etoposide)
Completed
- Intraocular Retinoblastoma
- liposomal vincristine sulfate
- +2 more
-
Birmingham, Alabama
- +55 more
Feb 16, 2021
Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Mitoxantrone hydrochloride liposome injection
- +4 more
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Aug 15, 2023
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- Vincristine Sulfate Liposomes Injection (VSLI)
- Vincristine Sulfate Injection (VSI)
-
La Jolla, California
- +14 more
Sep 6, 2021
Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin
Completed
- Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
- +2 more
- bleomycin sulfate
- +8 more
-
Birmingham, Alabama
- +176 more
Apr 1, 2022
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Marqibo® (vincristine sulfate liposomes injection)
-
Los Angeles, California
- +32 more
Feb 8, 2021
Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin's, Leukemia, T-Cell Trial in Memphis (Dexamethasone, Panobinostat, Liposomal
Terminated
- Acute Lymphoblastic Leukemia
- +3 more
- Dexamethasone
- +13 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 8, 2019
Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)
Not yet recruiting
- Rhabdomyosarcoma, Child
- Doxorubicin Hydrochloride Liposome+Irinotecan
- Temozolomide+Irinotecan+Vincristine
- (no location specified)
Jul 13, 2022
Locally Advanced Sarcoma Trial in Houston (Dexamethasone, Doxorubicin, Fosaprepitant Dimeglumine)
Terminated
- Locally Advanced Sarcoma
- Dexamethasone
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Aug 5, 2021
Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q, Stage IV Wilms Tumor Trial in Worldwide (drug,
Active, not recruiting
- Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q
- Stage IV Wilms Tumor
- doxorubicin hydrochloride
- +6 more
-
Birmingham, Alabama
- +206 more
Mar 23, 2022
Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in
Active, not recruiting
- Stage I Mantle Cell Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Buffalo, New York
- +1 more
Mar 9, 2022
Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)
Active, not recruiting
- Small Cell Lung Cancer
- Irinotecan liposome injection
- Topotecan
-
Denver, Colorado
- +117 more
Nov 22, 2022
Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Relapsing Multiple Sclerosis
- Mitoxantrone Hydrochloride Liposome Injection
-
Beijing, Beijing, ChinaXuanwu Hospital Capital Medical University
Aug 9, 2022
Sarcoma, Neuroblastoma, Wilms Tumor Trial run by the (Marqibo)
Completed
- Sarcoma
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2020
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Cyclophosphamide
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 18, 2022